AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed.
AZN Key Statistics
Stock Snapshot
With a market cap of 280.73B, AstraZeneca(AZN) trades at $90.41. The stock has a price-to-earnings ratio of 29.71 and currently yields dividends of 1.7%.
On 2025-12-07, AstraZeneca(AZN) stock moved within a range of $90.07 to $91.18. With shares now at $90.41, the stock is trading +0.4% above its intraday low and -0.8% below the session's peak.
Trading volume for AstraZeneca(AZN) stock has reached 5.43M, versus its average volume of 5.74M.
The stock's 52-week range extends from a low of $61.24 to a high of $94.02.
The stock's 52-week range extends from a low of $61.24 to a high of $94.02.
AZN News
Salesforce (CRM) announced that the pharmaceutical giant AstraZeneca (AZN) will deploy Agentforce Life Sciences for Customer Engagement across its global operat...
Salesforce (CRM) “announced that AstraZeneca (AZN) has selected Agentforce Life Sciences for Customer Engagement to help transform its customer engagement globa...
The company stated: “AstraZeneca (AZN) advances its ambition to redefine hematology care with new data from its diverse pipeline and portfolio at the 67th Ameri...
Analyst ratings
80%
of 30 ratingsMore AZN News
On Tuesday, the U.S. Food and Drug Administration accepted AstraZeneca Plc's (NASDAQ:AZN) New Drug Application (NDA) for baxdrostat for adult patients with hard...
(RTTNews) - AstraZeneca's (AZN) New Drug Application (NDA) for experimental hypertension drug baxdrostat has been granted Priority Review by the U.S. Food and D...
